On July 23, the World Health Organization (WHO) recognized the outbreak of Monkeypox virus infections, with its epicenter in Europe, as a public health emergency of international concern (USPPI ).
The vaccine authorized in France, IMVANEX not being immediately availablethe Council of Ministers authorized the marketing of the JYNNEOS smallpox vaccine, made available by the State, in order to rapidly stem a possible epidemic in French Polynesia.
Both IMVANEX and JYNNEOS vaccines are manufactured by the same company and are identical in terms of efficacy and safety profile.
